Arkolith/Insider Trading/BTTX/Form 4

Karbe Frank

Chief Executive Officer, DirectorBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Jul 31, 2023
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 27, 2023Buy(P)137K$0.73$100K429K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-035680) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML